Sevelamer: new kid on the block no match for old standard

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1252, 2000-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vernakalant for the Conversion of Atrial Fibrillation: The New Kid On the Block?

By Conde Diego Baranchuk Adrian

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 4, 2014-07 ,pp. : 299-302

Blackwell Publishing

Access to resources Recommend Favorite

New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 5, 2015-06 ,pp. : 677-686

Bentham Science Publishers

Access to resources Recommend Favorite

Azithromycin microspheres a match for standard therapy

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Sestrins: A New Kid for Stroke Treatment?

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 797-806

Bentham Science Publishers

Access to resources Recommend Favorite

Tigecycline a match for standard therapy in complicated infections

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite